| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston,, Massachusetts 02114
Address all correspondence and requests for reprints to: Marie B. Demay, M.D., Endocrine Unit, Wellman 501, 32 Fruit Street, Massa-chusetts General Hospital, Boston, Massachusetts 02114.
The Vitamin D receptor (VDR), a member of the nuclear receptor superfamily, mediates the effects of 1,25-dihydroxyvitamin D3 on mineral ion homeostasis. Although the mammalian and avian VDRs have been extensively studied, little is known about the VDR in lower vertebrate species. To address this, we have isolated the Xenopus laevis VDR (xVDR) complementary DNA. Overall, the xVDR shares 79%, 73%, 73%, and 75% identity at the amino acid level with the chicken, mouse, rat, and human VDRs, respectively. The amino acid residues and subdomains important for DNA binding, hormone binding, dimerization, and transactivation are mostly conserved among all VDR species.
The xVDR polypeptide can heterodimerize with the mouse retinoid X
receptor
, bind to the rat osteocalcin vitamin D response element
(VDRE), and induce vitamin D-dependent transactivation in transfected
mammalian cells. Northern analysis reveals two xVDR messenger RNA
species of 2.2 kb and 1.8 kb in stage 60 Xenopus
tissues. In the adult, xVDR expression is detected in many tissues
including kidney, intestine, skin, and bone. During
Xenopus development, xVDR messenger RNA first appears at
developmental stage 13 (preneurulation), increasing to maximum at
stages 5761 (metamorphosis). Our data demonstrate that, in
Xenopus, VDR expression is developmentally regulated and
that the vitamin D endocrine system is highly conserved during
evolution.
This article has been cited by other articles:
![]() |
D. L. Howarth, S. H. W. Law, B. Barnes, J. M. Hall, D. E. Hinton, L. Moore, J. M. Maglich, J. T. Moore, and S. W. Kullman Paralogous Vitamin D Receptors in Teleosts: Transition of Nuclear Receptor Function Endocrinology, May 1, 2008; 149(5): 2411 - 2422. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. Whitfield, H. T. L. Dang, S. F. Schluter, R. M. Bernstein, T. Bunag, L. A. Manzon, G. Hsieh, C. Encinas Dominguez, J. H. Youson, M. R. Haussler, et al. Cloning of a Functional Vitamin D Receptor from the Lamprey (Petromyzon marinus), an Ancient Vertebrate Lacking a Calcified Skeleton and Teeth Endocrinology, June 1, 2003; 144(6): 2704 - 2716. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Crofts, M. S. Hancock, N. A. Morrison, and J. A. Eisman Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts PNAS, September 1, 1998; 95(18): 10529 - 10534. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jehan and H. F. DeLuca Cloning and characterization of the mouse vitamin D receptor promoter PNAS, September 16, 1997; 94(19): 10138 - 10143. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Li, A. E. Pirro, M. Amling, G. Delling, R. Baron, R. Bronson, and M. B. Demay Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia PNAS, September 2, 1997; 94(18): 9831 - 9835. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |